The clinical benefit of topical moisturizers in xerosis patient
Not Applicable
Completed
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0001508
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
1.All patients were between the ages of 20 and 70 (male or female)
2.All patients had a diagnosis of xerosis as defined by the xerosis severity scale (XSS) presented by Rogers et al and scores of at least 3 on both shins.
3.All of the included patients signed written informed consent for their participation.
Exclusion Criteria
Patients were excluded if there was known or suspected sensitivity to test ingredients, current history of any dermatologic diseases requiring treatment (such as psoriasis, atopic dermatitis and eczema), a condition that could interfere with the study’s conduct, use of oral/topical corticosteroids or immunosuppressants, or light therapy within 4 weeks prior to the study.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Xerosis Severity scale;Transepidermal water loss;skin hydration status (corneometer)
- Secondary Outcome Measures
Name Time Method Pruritus grade;Tenderness grade;The Investigator global assessment (IGA) and Subject global assessment (SGA)